ACOD1 and metabolic dysfunction-associated steatohepatitis: We hypothesize that the increased Irg1 expression and itaconate production during NASH serves as an important mechanism whereby excess lipid is metabolized by the liver; although Irg1 expression is helpful, it is clearly not sufficient to prevent all aspects of the disorder.